Leesburg-based Theragen acquires Neurotech North America
Leesburg-based Theragen LLC, a privately owned medical device company, has acquired Neurotech North America, a manufacturer of noninvasive stimulation products for orthopedic and spinal indications.
Financial details of the acquisition were not disclosed.
Theragen is focused on developing noninvasive therapeutics for the treatment of disease and pain. The company said this acquisition marks its commercial entry into the noninvasive therapeutics industry.
Neurotech NA was a subsidiary of an Irish company, BioMedical Research Inc. Its primary products include Kneehab XP, cleared for quadriceps strengthening; and Neurotech Recovery Back, a transcutaneous electrical nerve stimulation (TENS) and neuromuscular electrical nerve stimulation (NMES) technologycleared for treatment of the lower back.
“Neurotech’s products are proven and possess an exceptional safety record,” Gary Grenter, the president and CEO of Theragen, said in a statement. “After focusing the past 18 months on our R&D efforts, we are excited about entering the non-invasive therapeutics industry with these excellent products.”
“Theragen’s mission is to develop non-invasive therapeutic solutions using electrical, mechanical and other forms of energy that will provide relief for sufferers” before and after survey, Kimball Chen, Theragen’s chairman of the board, said in a statement.
Theragen LLC is focused on developing non-invasive therapeutics for the treatment of disease and pain. To learn more about Theragen, including the Neurotech NA product lines, visit: www.theragen.com.